Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sjögrens Disease”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT02240888
What this trial is testing

Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

Who this might be right for
RASLEVasculitis+3 more
Region Skane 300
Not applicableStudy completedNCT01470638
What this trial is testing

Flt3-Ligand Levels in Sjögrens Syndrome

Who this might be right for
Sjogrens Syndrome
Göteborg University 30
Testing effectiveness (Phase 2)Ended earlyNCT06531395
What this trial is testing

Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease

Who this might be right for
Sjögrens Disease
Kiniksa Pharmaceuticals International, plc 3
Large-scale testing (Phase 3)Study completedNCT02915159
What this trial is testing

Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

Who this might be right for
Sjogrens Disease
Bristol-Myers Squibb 250
Testing effectiveness (Phase 2)Looking for participantsNCT06805448
What this trial is testing

Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease

Who this might be right for
Sjorgren's Syndrome
Rigshospitalet, Denmark 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06293365
What this trial is testing

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Who this might be right for
Sjögrens DiseaseSystemic Lupus ErythematosusRheumatoid Arthritis
Novartis Pharmaceuticals 155